secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2023-04-12T23:59:59+00:00
Accession:  0001575872-23-000548
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Denali Capital extends business combination deadline to July 11, 2023 with $825K trust deposit
--------------------------------------------------------------------------------

- Deposited $825,000 into trust account to extend deadline from April 11 to July 11, 2023; first of two permitted three-month extensions.
- Issued convertible promissory note to sponsor for up to $825,000; initial $412,500 drawn, balance drawable; converts at $10 per share.
- Amendment to merger agreement ensures repayment of note at closing does not reduce the minimum cash condition.
- Business combination target is Longevity Biomedical, Inc.; merger agreement entered January 25, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000157587223000548/0001575872-23-000548-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000157587223000548/deca-20230411.htm
  HTML page:      https://secwatch.observer/filing/0001575872-23-000548

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer